Exact Mass: 334.1429688

Exact Mass Matches: 334.1429688

Found 19 metabolites which its exact mass value is equals to given mass value 334.1429688, within given mass tolerance error 1.6E-6 dalton. Try search metabolite list with more accurate mass tolerance error 3.2E-7 dalton.

(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

2-{4-[1-(hydroxyimino)-2,3-dihydro-1H-inden-5-yl]-3-(pyridin-4-yl)-1H-pyrazol-1-yl}ethan-1-ol

C19H18N4O2 (334.1429688)


   

Pimobendan

4,5-dihydro-6-(2-(4-Methoxyphenyl)-1H-benzimidazole-5-yl)-5-methyl-3(2H)-pyridazinone

C19H18N4O2 (334.1429688)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents

   

Purple pigment

Purple pigment

C19H18N4O2 (334.1429688)


   

Pimobendan (Vetmedin)

Pimobendan (Vetmedin)

C19H18N4O2 (334.1429688)


   

AZD1080

2-hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile

C19H18N4O2 (334.1429688)


   

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester

4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester

C19H18N4O2 (334.1429688)


   

GDC-0879

(E)-5-(1-(2-Hydroxyethyl)-3-(pyridin-4-yl)-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime

C19H18N4O2 (334.1429688)


GDC-0879 is a potent and selective B-Raf inhibitor with an IC50 of 0.13 nM.

   

10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine

10,11-Dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine

C19H18N4O2 (334.1429688)


   

N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide

N-(3,4-dimethylphenyl)-4-oxo-3,10-dihydro-2H-pyrimido[1,2-a]benzimidazole-2-carboxamide

C19H18N4O2 (334.1429688)


   

Pimobendan

Pimobendan

C19H18N4O2 (334.1429688)


D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents

   

2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile

2-(2-Furanyl)-5-[4-(phenylmethyl)-1-piperazinyl]-4-oxazolecarbonitrile

C19H18N4O2 (334.1429688)


   

N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide

N3-(2,4-Dimethylphenyl)-N1-phenylpyrazole-1,3-dicarboxamide

C19H18N4O2 (334.1429688)


   

6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine

6-(3,5-dimethyl-4-isoxazolyl)-N-[1-(2-furanyl)ethyl]-4-quinazolinamine

C19H18N4O2 (334.1429688)


   

Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate

Ethyl (3E)-3-phenyl-3-(quinazolin-4-ylhydrazinylidene)propanoate

C19H18N4O2 (334.1429688)


   

2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

2-[(2E)-2-[1-(4-methoxyphenyl)ethylidene]hydrazinyl]-4-phenyl-1H-pyrimidin-6-one

C19H18N4O2 (334.1429688)


   

N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide

N-[(Z)-[2-(1H-imidazol-2-yl)-1-phenylethylidene]amino]-4-methoxybenzamide

C19H18N4O2 (334.1429688)


   

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[2-(1h-indol-3-yl)ethenyl]ethanimidic acid

C19H18N4O2 (334.1429688)


   

(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole

(5e)-4-methoxy-5-({4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)-1'h-2,2'-bipyrrole

C19H18N4O2 (334.1429688)


   

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid

2-{[(2-aminophenyl)(hydroxy)methylidene]amino}-n-[(1e)-2-(1h-indol-3-yl)ethenyl]ethanimidic acid

C19H18N4O2 (334.1429688)